ANI Pharmaceuticals (ANIP)

[jeffqdhsr]

One other thought as it relates to both Libigel & Gvax

Considering Libigel patent pending applications were put in place back in 2011 and they been changed and modified recently its odd ANI has never mentioned them ! & why wouldn't they if you were holding a potential asset like well one that claims to reduce CV events in the female population would you as the CEO have any issue promoting , informing investors of what the objective is that your looking to accomplish ? Even Gvax news is quiet have they received any milestone s ? Or expect to ? What this boils down to is this ANI gave 47% of their stock to Bpax holders ? For what amounts to 18 Mil in cash then few years later built Co up to where it is today with out using any other portion of Bpax portfolio ! Sound believable, because that's where we are today , no knowledge or value in any other assets Bpax brought into deal. JMHO